Ovation iX Iliac Stent Graft TV-IL1422160-JRecalls & reported problems
Endologix LLC · The Ovation iX™ Iliac Limbs are components of the Ovation Prime, Ovation iX, and Alto™ Abdominal Stent Graft Systems. The Ovation iX™ Iliac Limbs are comprised of a nitinol stent encapsulated in low-permeability PTFE. The iliac limbs are deployed into the leg sections of the aortic body. Additional iliac limbs may be used to extend the length of the device, where indicated. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00850007370350), received between Mar 8, 2023 and Nov 21, 2025 — classified as 3 injuries.
The most frequently reported specific device problem is “Lack of Effect” (2 reports).
3 other recalls cover devices cleared under the same FDA submission (P120006); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Lack of Effect2
- Appropriate Device Problem Term/Code Not Available1
- Migration1
- Off-Label Use1
Patient problems
- Clinical Endoleak3
- Abdominal Pain1
- Aneurysm1
- Pseudoaneurysm1
- Ruptured Aneurysm1
- Unspecified Infection1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryNov 21, 2025Migration; Lack of Effect; Migration; Lack of Effect
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2025 WITH THE IMPLANT OF AN ALTO ABDOMINAL STENT GRAFT SYSTEM AND AN OVATION IX EXTENDER. THE PATIENT PRESENTED EMERGENTLY ON (B)(6) 2025 WITH ABDOMINAL PAIN AND A RUPTURED ANEURYSM. REPORTEDLY THE OVATION IX LIMB PULLED BACK INTO THE AORTA CAUSING A TYPE IB ENDOLEAK IN THE RIGHT COMMON ILIAC ARTERY. REINTERVENTION WAS COMPLETED ON (B)(6) 2025 WITH THE IMPLANT OF ANOTHER OVATION IX LIMB TO EXTEND TO THE RIGHT HYPOGASTRIC. THE TYPE IB ENDOLEAK ON THE RIGHT SIDE WAS SEALED. THE PATIENTS ABDOMINAL PAIN SUBSIDED AND WAS SYMPTOM FREE. ONE WEEK LATER ON (B)(6) 2025 THE PATIENT WAS BROUGHT BACK IN TO COMPLETE AN EXTENSION ON THE LEFT COMMON ILIAC ARTERY (LCIA). THERE WAS NO ENDOLEAK PRESENT IN THE LCIA BEFORE THE PROCEDURE. THE PHYSICIAN ELECTED TO IMPLANT AN OVATION IX LIMB TO EXTEND THE LCIA TO THE LEFT HYPOGASTRIC AS A PREVENTATIVE MEASURE. THE FINAL PATIENT STATUS WAS REPORTED TO BE WELL POST-SECONDARY PROCEDURES.
Patient problems: Abdominal Pain; Clinical Endoleak; Ruptured Aneurysm
MAUDE report 23618811 ↗InjuryMar 5, 2025Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
THE PATIENT WAS TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE IMPLANT OF THE ALTO ABDOMINAL STENT GRAFT SYSTEM ON (B)(6) 2024. IT WAS REPORTED ON (B)(6) 2025, DURING A ROUTINE FOLLOW UP, THE PATIENT PRESENTED WITH A TYPE IB ENDOLEAK. AN INTERVENTION IS PLANNED FOR (B)(6) 2025. THE PATIENT STATUS IS STABLE.
Patient problems: Clinical Endoleak
MAUDE report 21528170 ↗InjuryMar 8, 2023Off-Label Use; Lack of Effect; Off-Label Use; Lack of Effect
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH IMPLANT OF THE ALTO ABDOMINAL AORTIC ANEURYSM STENT SYSTEM. APPROXIMATELY THREE (3) MONTHS POST INITIAL PROCEDURE, THE PATIENT PRESENTED WITH A TYPE IB ENDOLEAK, AN INCREASED ANEURYSM SAC (UNKNOWN DIAMETER) OF THE LEFT EXTERNAL ILIAC ARTERY (LEIA), A CONTAINED PSEUDOANEURYSM AND GRAFT INFECTION. THE PATIENT HAS BEEN ADMINISTERED ANTIBIOTICS. THE PHYSICIAN ELECTED TO TREAT THE PATIENT BY COILING THE INTERNAL ILIAC ARTERY AND EXTENDING THE ILIAC STENT INTO THE LEIA WITH TWO (2) ADDITIONAL OVATION IX ILIAC LIMBS ON 21 FEBRUARY 2023 (IN ORDER TO EXCLUDE THE PERSISTENT SCIATIC ARTERY). BLOOD CULTURES WERE ALSO REPEATED, AND PATIENT IS REPORTEDLY IN STABLE CONDITION. THE PHYSICIANS PLANS TO FURTHER TREAT BY CONVERTING PATIENT TO OPEN REPAIR WITH EXPLANTATION OF THE GRAFT, BUT THIS SURGERY HAS NOT BEEN SCHEDULED.
Patient problems: Aneurysm; Clinical Endoleak; Pseudoaneurysm; Unspecified Infection
MAUDE report 16503518 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P120006. One submission often covers many models, so check the product and lot details in each record.
- Z-2263-2020 · May 6, 2020 · TerminatedOvation iX Abdominal Stent Graft Systems, REF: TV-AB2080-I, TV-AB2080-J, TV-AB2380-I, TV-AB2380-J, TV-AB2680-I, TV-AB2680-J, TV-AB2980-I, TV-AB2980-J, TV-AB3480-I, TV-AB3480-J
- Z-0125-2015 · Sep 20, 2014 · TerminatedOvation Prime Abdominal Stent Graft System - 29mm Aortic Body stent grafts. The TriVascular Ovation Prime Abdominal Stent Graft System is a low-profile endovascular device deliver
- Z-0288-2013 · Oct 19, 2012 · TerminatedTriVascular brand Fill Polymer Kit, Endovascular Graft, Aneurysm Treatment System, European Model Number: TVFP14-B, (in European distributor inventory only); PRODUCT Usage: The
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page